Edition:
United Kingdom

Amgen Inc (AMGN.OQ)

AMGN.OQ on NASDAQ Stock Exchange Global Select Market

169.81USD
6:41pm BST
Change (% chg)

$0.12 (+0.07%)
Prev Close
$169.69
Open
$169.74
Day's High
$169.81
Day's Low
$168.59
Volume
402,318
Avg. Vol
1,196,081
52-wk High
$210.18
52-wk Low
$166.30

Latest Key Developments (Source: Significant Developments)

Novartis' Sandoz unit defeats Amgen patent appeal related to white blood cell deficiency biosimilars
Wednesday, 8 May 2019 

May 8 (Reuters) - u.s. Appeals court rejects amgen appeal in patent litigation related to two novartis biosimilars -- court ruling:.  Full Article

Coherus Biosciences And Amgen Settle Trade Secrets Action
Thursday, 2 May 2019 

May 2 (Reuters) - Coherus BioSciences Inc ::COHERUS BIOSCIENCES AND AMGEN SETTLE TRADE SECRETS ACTION.COHERUS BIOSCIENCES - DETAILS OF SETTLEMENT ARE CONFIDENTIAL, COHERUS TO CONTINUE TO MARKET UDENYCA & PAY MID-SINGLE DIGIT ROYALTY TO AMGEN FOR 5 YEARS.COHERUS BIOSCIENCES - SETTLED TRADE SECRET ACTION BROUGHT BY AMGEN AGAINST COHERUS THAT WAS PENDING IN SUPERIOR COURT OF CALIFORNIA COUNTY OF VENTURA.  Full Article

Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
Thursday, 2 May 2019 

May 2 (Reuters) - Amgen Inc ::AMGEN AND SYAPSE ENTER PRECISION MEDICINE COLLABORATION IN ONCOLOGY.AMGEN INC - AMGEN AND SYAPSE WILL DEVELOP OBSERVATIONAL RESEARCH ANALYTICS TO ASSESS TREATMENT OUTCOMES FOR AREAS OF UNMET NEED IN ONCOLOGY.  Full Article

GE Healthcare Announces Digital Collaboration With Amgen To Improve Biomanufacturing Performance Reliability
Monday, 11 Mar 2019 

March 11 (Reuters) - GE Healthcare::GE HEALTHCARE ANNOUNCES DIGITAL COLLABORATION WITH AMGEN TO IMPROVE BIOMANUFACTURING PERFORMANCE RELIABILITY.  Full Article

Amgen Announces 2019 Second Quarter Dividend
Thursday, 7 Mar 2019 

March 7 (Reuters) - Amgen Inc ::AMGEN ANNOUNCES 2019 SECOND QUARTER DIVIDEND.SETS QUARTERLY DIVIDEND OF $1.45PER SHARE.  Full Article

U.S., EU Patent Office Invalidates Amgen Subsidiary's Patents Claiming Antibodies To IL-4 Receptor
Friday, 15 Feb 2019 

Feb 15 (Reuters) - Regeneron Pharmaceuticals Inc ::U.S. AND EU PATENT OFFICE DECISIONS INVALIDATE AMGEN SUBSIDIARY IMMUNEX'S PATENTS CLAIMING ANTIBODIES TO THE IL-4 RECEPTOR.REGENERON PHARMACEUTICALS INC - PATENT OFFICE DECISIONS ARE SUBJECT TO APPEAL BY IMMUNEX..  Full Article

Teva And Amgen Resolve Ongoing Dispute Over Teva’S Generic Cinacalet HCl Product
Thursday, 3 Jan 2019 

Jan 2 (Reuters) - Teva Pharmaceutical Industries Ltd ::TEVA AND AMGEN RESOLVE ONGOING DISPUTE OVER TEVA’S GENERIC CINACALET HCL PRODUCT.TEVA WILL PAY AMGEN AN UNDISCLOSED AMOUNT AS PART OF THE SETTLEMENT.THE AMOUNT AND OTHER TERMS OF SETTLEMENT REMAIN CONFIDENTIAL.TEVA PHARMACEUTICAL INDUSTRIES- LITIGATION BETWEEN PARTIES TO BE ENDED.TEVA PHARMACEUTICAL INDUSTRIES- CO AGREED TO STOP SELLING ITS GENERIC PRODUCT UNTIL LICENSE DATE IN MID 2021, OR EARLIER UNDER CERTAIN CIRCUMSTANCES.  Full Article

Amgen announces 10 percent increase in 2019 first quarter dividend
Friday, 7 Dec 2018 

Dec 7 (Reuters) - Amgen Inc ::AMGEN ANNOUNCES 10 PERCENT INCREASE IN 2019 FIRST QUARTER DIVIDEND.INCREASES QUARTERLY DIVIDEND BY 10 PERCENT.SETS QUARTERLY DIVIDEND OF $1.45PER SHARE.  Full Article

Amgen Receives CHMP Positive Opinion To Expand Use Of Blincyto
Friday, 16 Nov 2018 

Nov 16 (Reuters) - Amgen Inc ::AMGEN RECEIVES CHMP POSITIVE OPINION TO EXPAND USE OF BLINCYTO® (BLINATUMOMAB) IN PATIENTS WITH MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA.AMGEN INC - APPLICATION BASED ON DATA FROM PHASE 2 BLAST STUDY.  Full Article

Temasek Holdings (Private) Ltd Dissolves Share Stake In Walt Disney, Amgen and Biogen
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Temasek Holdings (Private) Ltd::TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN WALT DISNEY CO - SEC FILING.TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN AMGEN INC.TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN BIOGEN INC.TEMASEK HOLDINGS (PRIVATE) LTD CUTS SHARE STAKE IN ALEXION PHARMACEUTICALS INC BY 18.5 PERCENT TO 1.2 MILLION SHARES.TEMASEK HOLDINGS (PRIVATE) LTD REPORTS SHARE STAKE OF 4.5 MILLION SHARES IN FARFETCH LTD.TEMASEK HOLDINGS (PRIVATE) LTD - CHANGE IN HOLDINGS ARE AS OF SEPTEMBER 30, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2018.  Full Article

Deals of the day-Mergers and acquisitions

May 22 The following bids, mergers, acquisitions and disposals were reported by 1300 GMT on Wednesday: